Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis

Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis

Abstract Background Symptomatic patients with chronic obstructive pulmonary disease (COPD) and low exacerbation risk still have disease instability, which can be improved with better bronchodilation. We evaluated two long-acting bronchodilators individually and in combination on reducing exacerbatio...

Full description

Bibliographic Details
Main Authors: Ian Naya, Lee Tombs, David A. Lipson, Isabelle Boucot, Chris Compton
Format: Article
Language:English
Published: BMC 2019-03-01
Series:Respiratory Research
Subjects:
COPD
Maintenance therapy
Exacerbation risk
ICS
Long acting bronchodilators
Lung function
Online Access:http://link.springer.com/article/10.1186/s12931-019-1027-9

Internet

http://link.springer.com/article/10.1186/s12931-019-1027-9

Similar Items